Condition: Posterior Fossa Ependymal Tumor · Sponsor: University of California, San Francisco
This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
This description comes directly from the study's public registry record.
PNOC Operations Office · 415-502-1600 · PNOC041@ucsf.edu
Always discuss trial participation with your own doctor first.
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| St. Louis Children's Hospital, Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07226453